Cat. No. | Name/Description | Purity |
---|---|---|
A403208 | Minodronic acid monohydrate | 97% |
A254512 | 1-(2,3-Dichlorophenyl)ethanamine hydrochloride | 97% |
A1150708 | Nevanimibe | 99% |
A100859 | Salirasib | 98% |
A618355 | GGTI298 Trifluoroacetate | 98% |
A272770 | EPZ015666 | 98% |
A645812 | Perhexiline maleate | 98% |
A417980 | Ibiglustat | 98% |
A711197 | MAT2A inhibitor 1 | 98% |
A1466954 | FIDAS-3 | 95% |
A1251721 | K-604 2HCl | 98% |
A659746 | 4-Hydroxyphenylglyoxylate | 95% |
A257211 | Lonafarnib | 99% |
A1462732 | AG-270 | 97% |
A987602 | Isoastilbin | 98% |
A765852 | GGTI-2418 | 98% |
A412936 | Tipifarnib | 98% |
A1258789 | GDP-α-D-mannose disodium | 98% |
A1328405 | FIDAS-5 | 97% |
A1352619 | GOT1 inhibitor-1 | 98% |
Name/Description | Transferase ↓ ↑ | Other Targets | Purity | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tipifarnib |
+++
FTase, IC50: 0.6 nM |
99%+ | |||||||||||||||||
Tolcapone |
+
COMT, Ki: 30 nM |
99%+ | |||||||||||||||||
Lonafarnib |
+++
H-ras, IC50: 1.9 nM K-ras-4B, IC50: 2.8 nM |
99%+ | |||||||||||||||||
(E)-Daporinad |
++++
NMPRTase, Ki: 0.4 nM |
99%+ | |||||||||||||||||
FTI-277 HCl |
++++
FTase, IC50: 500 pM |
99%+ | |||||||||||||||||
A 922500 |
++
mouse DGAT-1, IC50: 24 nM human DGAT-1, IC50: 7 nM |
99%+ | |||||||||||||||||
Lomeguatrib |
++
O6-alkylguanine-DNA-alkyltransferas, IC50: 5 nM |
99%+ | |||||||||||||||||
PF-04620110 |
+
DGAT1, IC50: 19 nM |
98+% | |||||||||||||||||
LB42708 |
+++
FTase (K-Ras), IC50: 0.8 nM FTase (N-ras), IC50: 1.2 nM |
98% | |||||||||||||||||
GGTI298 Trifluoroacetate | ✔ | 98%+ | |||||||||||||||||
1. Hovering the mouse over the "+" can display the specific value of the relevant IC50. The more "+", the stronger the inhibitory effect. 2. "✔" Indicates that the compound has inhibitory effects on the corresponding subtypes, but there is currently no relevant data on the intensity of inhibition. |